✦ LIBER ✦

Synthesis and Structure−Activity Relationships of Phenylenebis(methylene)- Linked Bis-tetraazamacrocycles That Inhibit Human Immunodeficiency Virus Replication. 2. Effect of Heteroaromatic Linkers on the Activity of Bicyclams

✍ Scribed by Bridger, Gary J.; Skerlj, Renato T.; Padmanabhan, Sreenivasan; Martellucci, Stephen A.; Henson, Geoffrey W.; Abrams, Michael J.; Joao, Heidi C.; Witvrouw, Myriam; De Vreese, Karen; Pauwels, Rudi; De Clercq, Erik

Book ID: 127077477
Publisher: American Chemical Society
Year: 1996
Tongue: English
Weight: 527 KB
Volume: 39
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm950584t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and Structure−Activity Relatio

Synthesis and Structure−Activity Relationships of Phenylenebis(methylene)- Linked Bis-azamacrocycles That Inhibit HIV-1 and HIV-2 Replication by Antagonism of the Chemokine Receptor CXCR4

✍ Bridger, Gary J.; Skerlj, Renato T.; Padmanabhan, Sreenivasan; Martellucci, Step 📂 Article 📅 1999 🏛 American Chemical Society 🌐 English ⚖ 425 KB

32 Potent inhibition of human immunodefi

32 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Structure activity relationships: G. Bridger1, R. Skerlj1, S. Padmanabhan1, D. Thomton2, G. Henson1, M. Abrams1, R. Datema3, N. Yamamoto4, K. De Vreese4, R. Pauwels4 and E. De Clercq4. 1Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania 19380, USA; 2Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, United Kingdom; 3Sandoz Forschungsinstitut, A-1235 Vienna, Austria; and 4Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 73 KB

31 Potent inhibition of human immunodefi

31 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Synthesis and effects of substitution at the aromatic linker: R. Skerlj1, G. Bridger1, S. Padmanabhan1, D. Thornton2, M. Abrams1, G. Henson1, R. Datema3, N. Yamamoto4, K. De Vreese4, R. Pauwels4 and E. De Clercq4. 1Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania 19380, USA; 2Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, United Kingdom; 3Sandoz Forschungsinstitut, A-1235 Vienna, Austria; and 4Rega Institute for Medical Research, Katholieke Universtiteit Leuven, B-3000 Leuven, Belgium

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 73 KB